Publikationen

[Differentiated thyroid cancer - is less (therapy) more?]
Todica A, Ladurner R, Spitzweg C.
Dtsch Med Wochenschr. 2018 Apr;143(7):453-458. doi: 10.1055/s-0044-102192. Epub 2018 Apr 3. German.
PMID: 29614533

Tropomyosin receptor kinase: a novel target in screened neuroendocrine tumors.
Aristizabal Prada ET, Heinzle V, Knösel T, Nölting S, Spöttl G, Maurer J, Spitzweg C, Angele M, Schmidt N, Beuschlein F, Stalla GK, Blaser R, Kuhn KA, Auernhammer CJ.
Endocr Relat Cancer. 2018 May;25(5):547-560. doi: 10.1530/ERC-17-0201. Epub 2018 Mar 21.
PMID: 29563190

Supportive therapy in gastroenteropancreatic neuroendocrine tumors: Often forgotten but important.
Jin XF, Spampatti MP, Spitzweg C, Auernhammer CJ.
Rev Endocr Metab Disord. 2018 Feb 20. doi: 10.1007/s11154-018-9443-6. [Epub ahead of print] Review.
PMID: 29464446

Advanced neuroendocrine tumours of the small intestine and pancreas: clinical developments, controversies, and future strategies.
Auernhammer CJ, Spitzweg C, Angele MK, Boeck S, Grossman A, Nölting S, Ilhan H, Knösel T, Mayerle J, Reincke M, Bartenstein P.
Lancet Diabetes Endocrinol. 2018 May;6(5):404-415. doi: 10.1016/S2213-8587(17)30401-1. Epub 2017 Dec 8. Review.
PMID: 29229497

EGFR-targeted nonviral NIS gene transfer for bioimaging and therapy of disseminated colon cancer metastases.
Urnauer S, Müller AM, Schug C, Schmohl KA, Tutter M, Schwenk N, Rödl W, Morys S, Ingrisch M, Bertram J, Bartenstein P, Clevert DA, Wagner E, Spitzweg C.
Oncotarget. 2017 Sep 16;8(54):92195-92208. doi: 10.18632/oncotarget.21028. eCollection 2017 Nov 3.
PMID: 29190908

Reintroducing the Sodium-Iodide Symporter to Anaplastic Thyroid Carcinoma.
Schmohl KA, Dolp P, Schug C, Knoop K, Klutz K, Schwenk N, Bartenstein P, Nelson PJ, Ogris M, Wagner E, Spitzweg C.
Thyroid. 2017 Dec;27(12):1534-1543. doi: 10.1089/thy.2017.0290. Epub 2017 Nov 10.
PMID: 29032724

[Thyroid emergencies : Thyroid storm and myxedema coma].
Spitzweg C, Reincke M, Gärtner R.
Internist (Berl). 2017 Oct;58(10):1011-1019. doi: 10.1007/s00108-017-0306-0. Review. German.
PMID: 28939923

EGFR Targeting and Shielding of pDNA Lipopolyplexes via Bivalent Attachment of a Sequence-Defined PEG Agent.
Morys S, Urnauer S, Spitzweg C, Wagner E.
Macromol Biosci. 2018 Jan;18(1). doi: 10.1002/mabi.201700203. Epub 2017 Sep 6.
PMID: 28877405

Outcome after resection of Adrenocortical Carcinoma liver metastases: a retrospective study.
Baur J, Büntemeyer TO, Megerle F, Deutschbein T, Spitzweg C, Quinkler M, Nawroth P, Kroiss M, Germer CT, Fassnacht M, Steger U; German Adrenocortical Carcinoma Study Group.
BMC Cancer. 2017 Aug 4;17(1):522. doi: 10.1186/s12885-017-3506-z.
PMID: 28778197

Systemic tumor-targeted sodium iodide symporter (NIS) gene therapy of hepatocellular carcinoma mediated by B6 peptide polyplexes.
Urnauer S, Klutz K, Grünwald GK, Morys S, Schwenk N, Zach C, Gildehaus FJ, Rödl W, Ogris M, Wagner E, Spitzweg C.
J Gene Med. 2017 May;19(5). doi: 10.1002/jgm.2957.
PMID: 28423213

Increased trace amine-associated receptor 1 (TAAR1) expression is associated with a positive survival rate in patients with breast cancer.
Vattai A, Akyol E, Kuhn C, Hofmann S, Heidegger H, von Koch F, Hermelink K, Wuerstlein R, Harbeck N, Mayr D, Spitzweg C, Toth B, Mahner S, Jeschke U, Ditsch N.
J Cancer Res Clin Oncol. 2017 Sep;143(9):1637-1647. doi: 10.1007/s00432-017-2420-8. Epub 2017 Apr 13.
PMID: 28409272

Imaging and targeted therapy of pancreatic ductal adenocarcinoma using the theranostic sodium iodide symporter (NIS) gene.
Schmohl KA, Gupta A, Grünwald GK, Trajkovic-Arsic M, Klutz K, Braren R, Schwaiger M, Nelson PJ, Ogris M, Wagner E, Siveke JT, Spitzweg C.
Oncotarget. 2017 May 16;8(20):33393-33404. doi: 10.18632/oncotarget.16499.
PMID: 28380420

Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma: results of a multicenter study in Germany.
Wendler J, Kroiss M, Gast K, Kreissl MC, Allelein S, Lichtenauer U, Blaser R, Spitzweg C, Fassnacht M, Schott M, Führer D, Tiedje V.
Eur J Endocrinol. 2016 Dec;175(6):521-529.
PMID: 27926471

Leveraging the immune system to treat advanced thyroid cancers.
French JD, Bible K, Spitzweg C, Haugen BR, Ryder M.
Lancet Diabetes Endocrinol. 2017 Jun;5(6):469-481. doi: 10.1016/S2213-8587(16)30277-7. Epub 2016 Oct 20. Review.
PMID: 27773653

Hypoxia-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated sodium iodide symporter gene delivery.
Müller AM, Schmohl KA, Knoop K, Schug C, Urnauer S, Hagenhoff A, Clevert DA, Ingrisch M, Niess H, Carlsen J, Zach C, Wagner E, Bartenstein P, Nelson PJ, Spitzweg C.
Oncotarget. 2016 Aug 23;7(34):54795-54810. doi: 10.18632/oncotarget.10758.
PMID: 27458162

The added value of 68Ga-DOTA-TATE-PET to contrast-enhanced CT for primary site detection in CUP of neuroendocrine origin.
Kazmierczak PM, Rominger A, Wenter V, Spitzweg C, Auernhammer C, Angele MK, Rist C, Cyran CC.
Eur Radiol. 2017 Apr;27(4):1676-1684. doi: 10.1007/s00330-016-4475-3. Epub 2016 Jul 19.

Fine Needle Aspiration in the Investigation of Thyroid Nodules.
Feldkamp J, Führer D, Luster M, Musholt TJ, Spitzweg C, Schott M.
Dtsch Arztebl Int. 2016 May 20;113(20):353-9. doi: 10.3238/arztebl.2016.0353. Review.
PMID: 27294815

Harnessing mesenchymal stem cell homing as an anticancer therapy.
Hagenhoff A, Bruns CJ, Zhao Y, von Lüttichau I, Niess H, Spitzweg C, Nelson PJ.
Expert Opin Biol Ther. 2016 Sep;16(9):1079-92. doi: 10.1080/14712598.2016.1196179. Epub 2016 Jun 13. Review.
PMID: 27270211

New drugs for medullary thyroid cancer: new promises?
Spitzweg C, Morris JC, Bible KC.
Endocr Relat Cancer. 2016 Jun;23(6):R287-97. doi: 10.1530/ERC-16-0104. Epub 2016 May 16. Review.
PMID: 27185870

Sequence-defined cMET/HGFR-targeted Polymers as Gene Delivery Vehicles for the Theranostic Sodium Iodide Symporter (NIS) Gene.
Urnauer S, Morys S, Krhac Levacic A, Müller AM, Schug C, Schmohl KA, Schwenk N, Zach C, Carlsen J, Bartenstein P, Wagner E, Spitzweg C.
Mol Ther. 2016 Aug;24(8):1395-404. doi: 10.1038/mt.2016.95. Epub 2016 May 9.
PMID: 27157666

Establishment of an Effective Radioiodide Thyroid Ablation Protocol in Mice.
Schmohl KA, Müller AM, Schwenk N, Knoop K, Rijntjes E, Köhrle J, Heuer H, Bartenstein P, Göke B, Nelson PJ, Spitzweg C.
Eur Thyroid J. 2015 Sep;4(Suppl 1):74-80. doi: 10.1159/000381019. Epub 2015 May 23.
PMID: 26601076

Life-threatening events in patients with pheochromocytoma.
Riester A, Weismann D, Quinkler M, Lichtenauer UD, Sommerey S, Halbritter R, Penning R, Spitzweg C, Schopohl J, Beuschlein F, Reincke M.
Eur J Endocrinol. 2015 Dec;173(6):757-64. doi: 10.1530/EJE-15-0483. Epub 2015 Sep 7.
PMID: 26346138

Thyroid hormones and tetrac: new regulators of tumour stroma formation via integrin αvβ3.
Schmohl KA, Müller AM, Wechselberger A, Rühland S, Salb N, Schwenk N, Heuer H, Carlsen J, Göke B, Nelson PJ, Spitzweg C.
Endocr Relat Cancer. 2015 Dec;22(6):941-52. doi: 10.1530/ERC-15-0245. Epub 2015 Aug 25.
PMID: 26307023

(124)I-PET Assessment of Human Sodium Iodide Symporter Reporter Gene Activity for Highly Sensitive In Vivo Monitoring of Teratoma Formation in Mice.
Lehner S, Lang C, Kaissis G, Todica A, Zacherl MJ, Boening G, Spitzweg C, Herbach N, Franz WM, Krause BJ, Steinhoff G, Bartenstein P, Hacker M, David R.
Mol Imaging Biol. 2015 Dec;17(6):874-83. doi: 10.1007/s11307-015-0857-1.
PMID: 25896817

Quantification of in vitro mesenchymal stem cell invasion into tumor spheroids using selective plane illumination microscopy.
Rühland S, Wechselberger A, Spitzweg C, Huss R, Nelson PJ, Harz H.
J Biomed Opt. 2015 Apr;20(4):040501. doi: 10.1117/1.JBO.20.4.040501.
PMID: 25839427

Mesenchymal stem cell-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene.
Knoop K, Schwenk N, Schmohl K, Müller A, Zach C, Cyran C, Carlsen J, Böning G, Bartenstein P, Göke B, Wagner E, Nelson PJ, Spitzweg C.
J Nucl Med. 2015 Apr;56(4):600-6. doi: 10.2967/jnumed.114.146662. Epub 2015 Mar 5.
PMID: 25745085

[Advanced radioiodine-refractory differentiated thyroid cancer].
Spitzweg C, Auernhammer CJ, Geisler J, Böck S, Heinemann V, Bartenstein P, Göke B.
Dtsch Med Wochenschr. 2015 Feb;140(3):168-71. doi: 10.1055/s-0041-100196. Epub 2015 Feb 6. Review. German. No abstract available.
PMID: 25658401

[Thyroid dysfunction in pregnancy].
Führer D, Mann K, Feldkamp J, Krude H, Spitzweg C, Kratzsch J, Schott M.
Dtsch Med Wochenschr. 2014 Oct;139(42):2148-52. doi: 10.1055/s-0034-1387300. Epub 2014 Oct 7. Review. German.
PMID: 25289925

Impact of (68)Ga-DOTATATE PET/CT on the surgical management of primary neuroendocrine tumors of the pancreas or ileum.
Ilhan H, Fendler WP, Cyran CC, Spitzweg C, Auernhammer CJ, Gildehaus FJ, Bartenstein P, Angele MK, Haug AR.
Ann Surg Oncol. 2015 Jan;22(1):164-71. doi: 10.1245/s10434-014-3981-2. Epub 2014 Sep 5.
PMID: 25190113

Best supportive care from the conservative/non-surgical perspective and its costs in the treatment of patients with advanced medullary thyroid cancer: results of a Delphi panel.
Kreissl MC, Jacob C, Führer D, Karges W, Luster M, Lux MP, Mann K, Mittendorf T, Schott M, Spitzweg C, Schmoll HJ.
Oncol Res Treat. 2014;37(6):316-22. doi: 10.1159/000362613. Epub 2014 May 12.
PMID: 24903762

Advanced radioiodine-refractory differentiated thyroid cancer: the sodium iodide symporter and other emerging therapeutic targets.
Spitzweg C, Bible KC, Hofbauer LC, Morris JC.
Lancet Diabetes Endocrinol. 2014 Oct;2(10):830-42. doi: 10.1016/S2213-8587(14)70051-8. Epub 2014 Jun 2. Review.
PMID: 24898835

32.
Neuroendocrine tumors of the bronchopulmonary system (typical and atypical carcinoid tumors): current strategies in diagnosis and treatment. Conclusions of an expert meeting February 2011 in Weimar, Germany.
Hörsch D, Schmid KW, Anlauf M, Darwiche K, Denecke T, Baum RP, Spitzweg C, Grohé C, Presselt N, Stremmel C, Heigener DF, Serke M, Kegel T, Pavel M, Waller CF, Deppermann KM, Arnold R, Huber RM, Weber MM, Hoffmann H.
Oncol Res Treat. 2014;37(5):266-76. doi: 10.1159/000362430. Epub 2014 Apr 14. Review.
PMID: 24853787

Treatment with octreotide in patients with well-differentiated neuroendocrine tumors of the ileum: prognostic stratification with Ga-68-DOTA-TATE positron emission tomography.
Koch W, Auernhammer CJ, Geisler J, Spitzweg C, Cyran CC, Ilhan H, Bartenstein P, Haug AR.
Mol Imaging. 2014;13:1-10.
PMID: 24824963

Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial.
Brose MS, Nutting CM, Jarzab B, Elisei R, Siena S, Bastholt L, de la Fouchardiere C, Pacini F, Paschke R, Shong YK, Sherman SI, Smit JW, Chung J, Kappeler C, Peña C, Molnár I, Schlumberger MJ; DECISION investigators.
Lancet. 2014 Jul 26;384(9940):319-28. doi: 10.1016/S0140-6736(14)60421-9. Epub 2014 Apr 24.
PMID: 24768112

EGFR-Targeted Adenovirus Dendrimer Coating for Improved Systemic Delivery of the Theranostic NIS Gene.
Grünwald GK, Vetter A, Klutz K, Willhauck MJ, Schwenk N, Senekowitsch-Schmidtke R, Schwaiger M, Zach C, Wagner E, Göke B, Holm PS, Ogris M, Spitzweg C.
Mol Ther Nucleic Acids. 2013 Nov 5;2:e131. doi: 10.1038/mtna.2013.58.
PMID: 24193032

Neuroendocrine tumor recurrence: diagnosis with 68Ga-DOTATATE PET/CT.
Haug AR, Cindea-Drimus R, Auernhammer CJ, Reincke M, Beuschlein F, Wängler B, Uebleis C, Schmidt GP, Spitzweg C, Bartenstein P, Hacker M.
Radiology. 2014 Feb;270(2):517-25. doi: 10.1148/radiol.13122501. Epub 2013 Oct 28.
PMID: 24056402

Systemic image-guided liver cancer radiovirotherapy using dendrimer-coated adenovirus encoding the sodium iodide symporter as theranostic gene.
Grünwald GK, Vetter A, Klutz K, Willhauck MJ, Schwenk N, Senekowitsch-Schmidtke R, Schwaiger M, Zach C, Wagner E, Göke B, Holm PS, Ogris M, Spitzweg C.
J Nucl Med. 2013 Aug;54(8):1450-7. doi: 10.2967/jnumed.112.115493. Epub 2013 Jul 10.
PMID: 23843567

Stromal targeting of sodium iodide symporter using mesenchymal stem cells allows enhanced imaging and therapy of hepatocellular carcinoma.
Knoop K, Schwenk N, Dolp P, Willhauck MJ, Zischek C, Zach C, Hacker M, Göke B, Wagner E, Nelson PJ, Spitzweg C.
Hum Gene Ther. 2013 Mar;24(3):306-16. doi: 10.1089/hum.2012.104.
PMID: 23402366

Adenoviral vectors coated with PAMAM dendrimer conjugates allow CAR independent virus uptake and targeting to the EGF receptor.
Vetter A, Virdi KS, Espenlaub S, Rödl W, Wagner E, Holm PS, Scheu C, Kreppel F, Spitzweg C, Ogris M.
Mol Pharm. 2013 Feb 4;10(2):606-18. doi: 10.1021/mp300366f. Epub 2013 Jan 18.
PMID: 23281933

Sodium iodide symporter (NIS)-mediated radiovirotherapy of hepatocellular cancer using a conditionally replicating adenovirus.
Grünwald GK, Klutz K, Willhauck MJ, Schwenk N, Senekowitsch-Schmidtke R, Schwaiger M, Zach C, Göke B, Holm PS, Spitzweg C.
Gene Ther. 2013 Jun;20(6):625-33. doi: 10.1038/gt.2012.79. Epub 2012 Oct 4.

Subcellular distribution of the sodium iodide symporter in benign and malignant thyroid tissues.
Kollecker I, von Wasielewski R, Langner C, Müller JA, Spitzweg C, Kreipe H, Brabant G.
Thyroid. 2012 May;22(5):529-35. doi: 10.1089/thy.2011.0311.
PMID: 22545753

[Medicinal therapy of metastasized neuroendocrine tumors of the gastroenteropancreatic system.]
Auernhammer CJ, Spitzweg C, Heinemann V, Göke B.
Internist (Berl). 2012 Feb 2. [Epub ahead of print] German.
PMID: 22294240

Chromogranin a as serum marker for gastroenteropancreatic neuroendocrine tumors: a single center experience and literature review.
Nölting S, Kuttner A, Lauseker M, Vogeser M, Haug A, Herrmann KA, Hoffmann JN, Spitzweg C, Göke B, Auernhammer CJ.
Cancers (Basel). 2012 Feb 15;4(1):141-55. doi: 10.3390/cancers4010141.
PMID: 24213232

An unusual case of ectopic ACTH syndrome.
Willhauck MJ, Pöpperl G, Rachinger W, Giese A, Auernhammer CJ, Spitzweg C.
Exp Clin Endocrinol Diabetes. 2012 Feb;120(2):63-7. doi: 10.1055/s-0031-1297967. Epub 2011 Dec 20.
PMID: 22187295

Image-guided tumor-selective radioiodine therapy of liver cancer after systemic nonviral delivery of the sodium iodide symporter gene.
Klutz K, Willhauck MJ, Dohmen C, Wunderlich N, Knoop K, Zach C, Senekowitsch-Schmidtke R, Gildehaus FJ, Ziegler S, Fürst S, Göke B, Wagner E, Ogris M, Spitzweg C.
Hum Gene Ther. 2011 Dec;22(12):1563-74. doi: 10.1089/hum.2011.041. Epub 2011 Oct 11.
PMID: 21851208 Free PMC Article
Similar articles
Select item 21755051

Functional Imaging of Pheochromocytoma with Ga-DOTATOC and C-HED in a Genetically Defined Rat Model of Multiple Endocrine Neoplasia.
Miederer M, Molatore S, Marinoni I, Perren A, Spitzweg C, Reder S, Wester HJ, Buck AK, Schwaiger M, Pellegata NS.
Int J Mol Imaging. 2011;2011:175352. doi: 10.1155/2011/175352. Epub 2011 Jun 8.
PMID: 21755051 Free PMC Article
Similar articles
Select item 21644815

Disconnecting the yin and yang relation of epidermal growth factor receptor (EGFR)-mediated delivery: a fully synthetic, EGFR-targeted gene transfer system avoiding receptor activation.
Schäfer A, Pahnke A, Schaffert D, van Weerden WM, de Ridder CM, Rödl W, Vetter A, Spitzweg C, Kraaij R, Wagner E, Ogris M.
Hum Gene Ther. 2011 Dec;22(12):1463-73. doi: 10.1089/hum.2010.231. Epub 2011 Aug 10.
PMID: 21644815 Free PMC Article
Similar articles
Select item 21611920

[New therapeutic options for advanced thyroid cancer].
Willhauck MJ, Schott M, Kreissl MC, Fassnacht M, Spitzweg C.
Dtsch Med Wochenschr. 2011 Jun;136(22):1165-8. doi: 10.1055/s-0031-1280531. Epub 2011 May 24. German. No abstract available.
PMID: 21611920

Image-guided, tumor stroma-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated NIS gene delivery.
Knoop K, Kolokythas M, Klutz K, Willhauck MJ, Wunderlich N, Draganovici D, Zach C, Gildehaus FJ, Böning G, Göke B, Wagner E, Nelson PJ, Spitzweg C.
Mol Ther. 2011 Sep;19(9):1704-13. doi: 10.1038/mt.2011.93. Epub 2011 May 17.
PMID: 21587211
Sodium iodide symporter (NIS)-mediated radionuclide ((131)I, (188)Re) therapy of liver cancer after transcriptionally targeted intratumoral in vivo NIS gene delivery.
Klutz K, Willhauck MJ, Wunderlich N, Zach C, Anton M, Senekowitsch-Schmidtke R, Göke B, Spitzweg C.
Hum Gene Ther. 2011 Nov;22(11):1403-12. doi: 10.1089/hum.2010.158. Epub 2011 Jun 28.
PMID: 21488714

Epidermal growth factor receptor-targeted (131)I-therapy of liver cancer following systemic delivery of the sodium iodide symporter gene.
Klutz K, Schaffert D, Willhauck MJ, Grünwald GK, Haase R, Wunderlich N, Zach C, Gildehaus FJ, Senekowitsch-Schmidtke R, Göke B, Wagner E, Ogris M, Spitzweg C.
Mol Ther. 2011 Apr;19(4):676-85. doi: 10.1038/mt.2010.296. Epub 2011 Jan 18.
PMID: 21245850

Thyroid function in breast cancer patients.
Ditsch N, Liebhardt S, Von Koch F, Lenhard M, Vogeser M, Spitzweg C, Gallwas J, Toth B.
Anticancer Res. 2010 May;30(5):1713-7.
PMID: 20592366

[Thyroid diseases and hypertension].
Spitzweg C, Reincke M.
Internist (Berl). 2010 May;51(5):603-4, 606-8, 610. doi: 10.1007/s00108-009-2499-3. German.
PMID: 20358170

Stimulation of retinoic acid-induced functional sodium iodide symporter (NIS) expression and cytotoxicity of ¹³¹I by carbamazepine in breast cancer cells.
Willhauck MJ, O Kane DJ, Wunderlich N, Göke B, Spitzweg C.
Breast Cancer Res Treat. 2011 Jan;125(2):377-86. doi: 10.1007/s10549-010-0835-x. Epub 2010 Mar 19.
PMID: 20300827

The biology of the sodium iodide symporter and its potential for targeted gene delivery.
Hingorani M, Spitzweg C, Vassaux G, Newbold K, Melcher A, Pandha H, Vile R, Harrington K.
Curr Cancer Drug Targets. 2010 Mar;10(2):242-67. Review.
PMID: 20201784

Genetics and phenomics of hypothyroidism and goiter due to NIS mutations.
Spitzweg C, Morris JC.
Mol Cell Endocrinol. 2010 Jun 30;322(1-2):56-63. doi: 10.1016/j.mce.2010.02.007. Epub 2010 Feb 12. Review.
PMID: 20153805

Targeted radioiodine therapy of neuroblastoma tumors following systemic nonviral delivery of the sodium iodide symporter gene.
Klutz K, Russ V, Willhauck MJ, Wunderlich N, Zach C, Gildehaus FJ, Göke B, Wagner E, Ogris M, Spitzweg C.
Clin Cancer Res. 2009 Oct 1;15(19):6079-86. doi: 10.1158/1078-0432.CCR-09-0851. Epub 2009 Sep 29.
PMID: 19789324

The German ACROSTUDY: past and present.
Buchfelder M, Schlaffer S, Droste M, Mann K, Saller B, Brübach K, Stalla GK, Strasburger CJ; German Pegvisomant Observational Study.
Eur J Endocrinol. 2009 Nov;161 Suppl 1:S3-S10. doi: 10.1530/EJE-09-0350. Epub 2009 Aug 14.
PMID: 19684061

Gene therapy in thyroid cancer.
Spitzweg C.
Horm Metab Res. 2009 Jun;41(6):500-9. doi: 10.1055/s-0029-1220744. Epub 2009 May 11. Review.
PMID: 19434562

Pituitary tumor size in acromegaly during pegvisomant treatment: experience from MR re-evaluations of the German Pegvisomant Observational Study.
Buchfelder M, Weigel D, Droste M, Mann K, Saller B, Brübach K, Stalla GK, Bidlingmaier M, Strasburger CJ; Investigators of German Pegvisomant Observational Study.
Eur J Endocrinol. 2009 Jul;161(1):27-35. doi: 10.1530/EJE-08-0910. Epub 2009 May 1.
PMID: 19411302